Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natural course and enzyme replacement therapy in mucopolysaccharidosis I, II, VI
2007-001453-26Phase 4Active
- Start
- Nov 2009
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of laronidase, idursulfase and galsulfase in mucopolysaccharidosis type I, mucopolysaccharidosis type 2, mucopolysaccharidosis type VI and 1 more (2 arms). Primary endpoint: Survival. Started Nov 2009; status: active.
02
Drugs
laronidaseidursulfasegalsulfase
03
Conditions
mucopolysaccharidosis type Imucopolysaccharidosis type 2mucopolysaccharidosis type VIMorquio syndrome
Beyond the preview
Go deeper on 2007-001453-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001453-26.